These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36111490)

  • 1. COVID-19 patient fibrinogen produces dense clots with altered polymerization kinetics, partially explained by increased sialic acid.
    Moiseiwitsch N; Zwennes N; Szlam F; Sniecinski R; Brown A
    J Thromb Haemost; 2022 Dec; 20(12):2909-2920. PubMed ID: 36111490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrin clots from patients with acute-on-chronic liver failure are weaker than those from healthy individuals and patients with sepsis without underlying liver disease.
    Driever EG; Muntz I; Patel V; Adelmeijer J; Bernal W; Koenderink GH; Lisman T
    J Thromb Haemost; 2023 Oct; 21(10):2747-2758. PubMed ID: 37336436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procoagulant changes in fibrin clot structure in patients with cirrhosis are associated with oxidative modifications of fibrinogen.
    Hugenholtz GC; Macrae F; Adelmeijer J; Dulfer S; Porte RJ; Lisman T; Ariëns RA
    J Thromb Haemost; 2016 May; 14(5):1054-66. PubMed ID: 26833718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential sialic acid content in adult and neonatal fibrinogen mediates differences in clot polymerization dynamics.
    Nellenbach K; Kyu A; Guzzetta N; Brown AC
    Blood Adv; 2021 Dec; 5(23):5202-5214. PubMed ID: 34555851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The alphaC domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis.
    Collet JP; Moen JL; Veklich YI; Gorkun OV; Lord ST; Montalescot G; Weisel JW
    Blood; 2005 Dec; 106(12):3824-30. PubMed ID: 16091450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Post-Translational Modifications of Fibrinogen on Clot Formation, Clot Structure, and Fibrinolysis: A Systematic Review.
    de Vries JJ; Snoek CJM; Rijken DC; de Maat MPM
    Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):554-569. PubMed ID: 31914791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lytic Susceptibility, Structure, and Mechanical Properties of Fibrin in Systemic Lupus Erythematosus.
    Litvinov RI; Nabiullina RM; Zubairova LD; Shakurova MA; Andrianova IA; Weisel JW
    Front Immunol; 2019; 10():1626. PubMed ID: 31379831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BβArg448Lys polymorphism is associated with altered fibrin clot structure and fibrinolysis in type 2 diabetes.
    Greenhalgh KA; Strachan MW; Alzahrani S; Baxter PD; Standeven KF; Storey RF; Ariens RA; Grant PJ; Price JF; Ajjan RA
    Thromb Haemost; 2017 Jan; 117(2):295-302. PubMed ID: 27929198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive Analysis of the Role of Fibrinogen and Thrombin in Clot Formation and Structure for Plasma and Purified Fibrinogen.
    Risman RA; Belcher HA; Ramanujam RK; Weisel JW; Hudson NE; Tutwiler V
    Biomolecules; 2024 Feb; 14(2):. PubMed ID: 38397467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance of gammaA/gamma' fibrin clots to fibrinolysis.
    Falls LA; Farrell DH
    J Biol Chem; 1997 May; 272(22):14251-6. PubMed ID: 9162058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interpretation and Validation of Maximum Absorbance Data Obtained from Turbidimetry Analysis of Plasma Clots.
    Pieters M; Guthold M; Nunes CM; de Lange Z
    Thromb Haemost; 2020 Jan; 120(1):44-54. PubMed ID: 31752041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryoprecipitate transfusion in trauma patients attenuates hyperfibrinolysis and restores normal clot structure and stability: Results from a laboratory sub-study of the FEISTY trial.
    Morrow GB; Feller T; McQuilten Z; Wake E; Ariëns RAS; Winearls J; Mutch NJ; Laffan MA; Curry N
    Crit Care; 2022 Sep; 26(1):290. PubMed ID: 36163263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Citrullinated fibrinogen forms densely packed clots with decreased permeability.
    Varjú I; Tóth E; Farkas ÁZ; Farkas VJ; Komorowicz E; Feller T; Kiss B; Kellermayer MZ; Szabó L; Wacha A; Bóta A; Longstaff C; Kolev K
    J Thromb Haemost; 2022 Dec; 20(12):2862-2872. PubMed ID: 36083779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the structural and mechanical effects of procoagulant agents on neonatal fibrin networks following cardiopulmonary bypass.
    Nellenbach K; Guzzetta NA; Brown AC
    J Thromb Haemost; 2018 Nov; 16(11):2159-2167. PubMed ID: 30182421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered fibrin clot structure and dysregulated fibrinolysis contribute to thrombosis risk in severe COVID-19.
    Wygrecka M; Birnhuber A; Seeliger B; Michalick L; Pak O; Schultz AS; Schramm F; Zacharias M; Gorkiewicz G; David S; Welte T; Schmidt JJ; Weissmann N; Schermuly RT; Barreto G; Schaefer L; Markart P; Brack MC; Hippenstiel S; Kurth F; Sander LE; Witzenrath M; Kuebler WM; Kwapiszewska G; Preissner KT
    Blood Adv; 2022 Feb; 6(3):1074-1087. PubMed ID: 34861681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA and histones impair the mechanical stability and lytic susceptibility of fibrin formed by staphylocoagulase.
    Komorowicz E; Farkas VJ; Szabó L; Cherrington S; Thelwell C; Kolev K
    Front Immunol; 2023; 14():1233128. PubMed ID: 37662916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dense and dangerous: The tissue plasminogen activator-resistant fibrinolysis shutdown phenotype is due to abnormal fibrin polymerization.
    Dow N; Coleman JR; Moore H; Osborn ZT; Sackheim AM; Hennig G; Butenas S; Nelson MT; Moore EE; Freeman K
    J Trauma Acute Care Surg; 2020 Feb; 88(2):258-265. PubMed ID: 31999655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia.
    Sauls DL; Lockhart E; Warren ME; Lenkowski A; Wilhelm SE; Hoffman M
    Biochemistry; 2006 Feb; 45(8):2480-7. PubMed ID: 16489740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational Prediction of the Interaction of Ivermectin with Fibrinogen.
    Vottero P; Tavernini S; Santin AD; Scheim DE; Tuszynski JA; Aminpour M
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sialic acid in fibrinogen: effects of sialic acid on fibrinogen-fibrin conversion by thrombin and properties of asialofibrin clot.
    Okude M; Yamanaka A; Morimoto Y; Akihama S
    Biol Pharm Bull; 1993 May; 16(5):448-52. PubMed ID: 8364489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.